Last $177.78 USD
Change Today -2.58 / -1.43%
Volume 1.6M
ALXN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 01/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Vikas Sinha M.B.A., C.A., CPA

Chief Financial Officer and Executive Vice President, Alexion Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

51$4,201,462
As of Fiscal Year 2013

Background*

Mr. Vikas Sinha, M.B.A., C.A., CPA has been the Chief Financial Officer of Alexion Pharmaceuticals, Inc. since October 2012 and has been its Executive Vice President since October 2012. Mr. Sinha served as Senior Vice President of Alexion Pharmaceuticals Inc., since September 2, 2005. Mr. Sinha also served at Bayer AG since June, 1994 holding various positions within Alexion Pharmaceuticals Inc. in the United States, Japan, Germany and Canada. He has been Vice President ...

Read Full Background

Corporate Headquarters*

352 Knotter Drive
Cheshire, Connecticut 06410

United States

Phone: 203-272-2596
Fax: 203-271-8198

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MBA
Asian Institute of Management

Other Affiliations*

Annual Compensation*

Salary$615,000
Total Annual Compensation$615,000

Stock Options*

Restricted Stock Awards$1,368,182
All Other Compensation$23,000
Exercised Options150,000
Exercised Options Value$16,103,793
Exercisable Options342,325
Exercisable Options Value$33,914,168
Unexercisable Options136,807
Unexercisable Options Value$8,200,773
Total Value of Options$58,218,734
Total Number of Options629,132

Total Compensation*

Total Annual Cash Compensation$1,313,000
Total Short Term Compensation$615,000
Other Long Term Compensation$1,391,182
Total Calculated Compensation$4,201,462
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALXN:US $177.78 USD -2.58

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
$876.9K
Stephen Edward Foots Group Chief Executive, Executive Director, Chairman of Group Executive Committee, Member of Nomination Committee, Member of Routine Business Committee, Member of Group Safety, Health & Environment Steering Committee, Member of Finance Committee and Member of Risk Management Committee
Croda International plc
535.0K GBP
Heinz-Jürgen Bertram Ph.D.Chairman of Executive Board, Chief Executive Officer and Labour Director
Symrise AG
€1.1M
Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)Co-Chairman, Chief Executive Officer, Member of The Management Council, Director, Member of Management Committee, Member of Stakeholders' Relationship Committee, Member of Investment Committee and Member of Corporate Social Responsibility Committee
Dr. Reddy's Laboratories Ltd.
6.3M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALEXION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.